300869 Contec Medical Systems
- 16.14
- +0.03+0.19%
Contec Medical Systems News
Kangtai Medical (300869.SZ) announced first-quarter results, net profit of 4.3519 million yuan, a decrease of 97.44%
Kangtai Medical (300869.SZ) released its report for the first quarter of 2024. The company's revenue was 9917...
Kangtai Medical (300869.SZ) announced its 2023 annual results, with net profit of 166 million yuan, a decrease of 15.51%
According to the Zhitong Finance App, Kangtai Medical (300869.SZ) released its 2023 annual report. The company's revenue was 747 million yuan, an increase of 4.89% over the previous year. Net profit attributable to shareholders of listed companies was 166 million yuan, a year-on-year decrease of 15.51%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 150 million yuan, an increase of 3.50% over the previous year. Basic earnings per share were $0.41. In addition, it is proposed to distribute a cash dividend of 3 yuan (tax included) for every 10 shares to all shareholders.
Express News | Kangtai Medical: Wholly-owned subsidiary obtains medical device registration certificate
Contec Medical Systems Gets Nod for Portable Sputum Suction Device
Medical instruments maker Contec Medical Systems (SHE:300869) received a medical device registration certificate for its portable sputum suction device, according to a Monday disclosure. The drug auth
Kangtai Medical (300869.SZ) subsidiary obtained four medical device registration certificates
Kangtai Medical (300869.SZ) announced that Changsha Kangtai Medical Core Biotechnology Co., Ltd., a wholly-owned subsidiary of the company...
Kangtai Medical (300869.SZ) subsidiary received a medical device registration certificate
Kangtai Medical (300869.SZ) announced that Changsha Kangtai Medical Core Biotechnology Co., Ltd., a wholly-owned subsidiary of the company...
Global Fetal Doppler Market Outlook & Forecast 2023-2028: Competitive Analysis for Contec Medical Systems, Huntleigh Healthcare, Promed Technology, The Cooper Companies & Ultrasound Technologies
The "Fetal Doppler Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global fetal Doppler ...
Kangtai Medical (300869.SZ) subsidiary obtained a medical device registration certificate
Kangtai Medical (300869.SZ) announced that Changsha Kangtai Medical Core Biotechnology Co., Ltd., a wholly-owned subsidiary of the company...
Kangtai Medical (300869.SZ): Has a variety of mesh nebulizers with micron-level atomization, low noise, easy to carry, and compression atomizers with adjustable speed
Gelonghui, December 7, Kangtai Medical (300869.SZ) stated on the investor interactive platform that nebulizers are commonly used medical devices for the treatment of various respiratory diseases. They have the advantages of safety, fast efficacy, high drug utilization rate, and suitable for all ages. The company has a variety of mesh nebulizers with micron-level atomization, low noise, easy to carry, and compression nebulizers with adjustable rate. They are suitable for patients requiring nebulization treatment to use at home, avoid cross-infection in hospitals, and reduce medical expenses and time. The company's products are sold on mainstream e-commerce platforms at home and abroad, such as JD, Tmall, Amazon, etc., and the products are highly cost-effective
Pulse Oximetry Market to Grow by USD 1,139.54 Million From 2022 to 2027|American Diagnostic Corp., Baxter International Inc., Contec Medical Systems Co. Ltd. and More Among the Key Companies - Technavio
The pulse oximetry market size is expected to grow by USD 1,139.54 million from 2022 to 2027, progressing at a CAGR of 8.27% as per the latest...
Kangtai Medical (300869.SZ): No high-pressure oxygen tank products
On October 31, Gelonghui, Kangtai Medical (300869.SZ) stated on the investor interactive platform that the company has no hyperbaric oxygen tank products yet.
Kangtai Medical (300869.SZ) released the first three quarter results, net profit of 195 million yuan, an increase of 12%
Kangtai Medical (300869.SZ) released its report for the third quarter of 2023. The company's revenue for the first three quarters was 6...
Some supervisors and executives of Kangtai Medical (300869.SZ) did not reduce their holdings at the end of the holdings reduction period
Kangtai Medical (300869.SZ) announced that the company's supervisor Gao Ruibin, senior managers Fu Chunyuan, Kou Guozhi, Liu...
Kangtai Medical (300869.SZ) announced first-half results, net profit of 183 million yuan, an increase of 58.51%
Kangtai Medical (300869.SZ) released the 2023 semi-annual report. During the reporting period, the company achieved operating income...
Kangtai Medical (300869.SZ): “Color Doppler Ultrasound Diagnosis System” obtained a medical device registration certificate
Kangtai Medical (300869.SZ) issued an announcement. The company recently obtained a certificate issued by the Hebei Drug Administration...
Kangtai Medical (300869.SZ) will list approximately 47.0473 million restricted shares and circulate on August 24
Kangtai Medical (300869.SZ) announced that the company's shares whose sale restrictions were lifted this time were before the company's initial public offering...
Kangtai Medical (300869.SZ) obtained a medical device registration certificate
Kangtai Medical (300869.SZ) announced that the company recently obtained “Medicine...” issued by the Hebei Drug Administration
Kangtai Medical (300869.SZ): Plans to use no more than 650 million yuan of convertible bonds temporarily idle to raise funds for cash management
On August 8, 2023, GLONGHUI | Kangtai Medical (300869.SZ) announced that on August 8, 2023, the company held the 3rd meeting of the 4th board of directors and the 2nd meeting of the 4th board of supervisors to deliberate and pass the “Proposal on Using Part of the Temporary Idle Raised Funds for Cash Management”, agreeing that the company will use no more than RMB 650 million in temporary idle corporate bonds for cash management. The period of use is valid for 12 months from the date of review and approval by the board of directors. In the above investment amounts and terms
Kangtai Medical (300869.SZ): “Medical Equipment Production Reform and Expansion Project” completed, raising a total of 99.1523 million yuan in savings to permanently supplement working capital
On August 8, 2023, GLONGHUI | Kangtai Medical (300869.SZ) announced that on August 8, 2023, the company held the 3rd meeting of the 4th board of directors and the 2nd meeting of the 4th board of supervisors to deliberate and pass the “Proposal on the Settlement of Medical Equipment Production and Expansion Projects and the Permanently Supplementing Liquidity Funds”, agreeing that the company will settle the initial public offering of the “Medical Equipment Production Reform and Expansion Project” for the total amount of funds raised as of July 31, 2023 (the specific amount is transferred to the bank's settlement balance on the same day as the bank settlement balance on the day of the day the funds were transferred to the bank's settlement balance on the day of the day the funds were transferred to the bank's settlement balance on the day of the day of the bank settlement (Preferential) Permanent liquidity replenishment
Kangtai Medical (300869.SZ): Executive Xu Yunlong completed holdings reduction of 390,000 shares
Glonway, July 31 | Kangtai Medical (300869.SZ) announced that recently, the company received a “Notice on the Completion of the Implementation of the Holding Reduction Plan” issued by senior management Xu Yunlong. As of the announcement date, Xu Yunlong's current share reduction plan has been completed. His holdings have been reduced by a total of 390,000 shares, accounting for 0.0971% of the total share capital.
Analysis
Price Target
No Data
